Hepatitis C Virus And Therapeutics

Global Industry Analysts
April 1, 2009
466 Pages - SKU: GJOB2271642
License type:
Countries covered: Global

This report analyzes the worldwide markets for Hepatitis C Virus And Therapeutics in US$ Millions. Annual forecasts are provided for each region for the period of 2006 through 2015. The report profiles 123 companies including many key and niche players such as Abbott Diagnostics, Achillion Pharmaceuticals, Inc., Anadys Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Hayashibara Biochemical Labs, Inc., HemispheRx Biopharma, Inc., Human Genome Sciences, Idenix Pharmaceuticals, Inc., Innogenetics NV, InterMune, Inc., Intarcia Therapeutics, Inc., Medivir AB, Merck & Co., Inc., Novartis AG, Chiron Corporation, Pfizer, Inc., Schering-Plough Corporation, Tibotec Pharmaceuticals Ltd., Tripep AB, Toray Industries, Inc., Valeant Pharmaceuticals International, and Vertex Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Titles available via "online download" are not affected by this and are still delivered to your reading room immediately.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


More Global Hepatitis Reports

2012 Global Hepatitis Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country by Venture Planning Group
The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...

Liver Disease Treatments: The Global Market by BCC Research
In 2009, the global market for drugs used to treat liver disease was worth approximately $12.4 billion. Sales in 2010 decreased and the market did ...

Hepatitis B Global Clinical Trials Review, H2, 2011 by GlobalData
Hepatitis B Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, “Hepatitis B Global Clinical Trials Review, H2, 2011 provides data on the Hepatitis ...

Global Hepatitis C Virus (HCV) Market- An Analysis by Koncept Analytics
Hepatitis C virus (HCV) is commonly spread through blood from a person who has been infected through use of shared needles or equipment used to ...

Disease and Therapy Review: Hepatitis C by Timely Data Resources, Inc.
The Hepatitis C Disease and Therapy Review provides an overview of the disease and related conditions, with incidence and prevalence numbers and percentages for major ...

See all reports like this >>